AUROPHARMA 1180.00 PE (PUT) 30 December 2025 options price chart analysis Aurobindo Pharma Limited

Live Options price premium & chart analysis for AUROPHARMA 1180.00 PE (PUT) 30 December 2025 options price chart analysis Aurobindo Pharma Limited

Aurobindo Pharma Limited AUROPHARMA trades in NSE under Pharmaceuticals NSE

AUROPHARMA 1180.00 PE Live prices

Spot price of AUROPHARMA: 1186.300 as on 30 Tue Dec 3:44pm
Day open: 1202.000 Range: 1179.000 to 1208.900

Option Price: AUROPHARMA PE 1180.00 2025-12-30 on 30 Tue Dec 2025

AUROPHARMA 1180.00 PE is trading at 0.05 on 3:29pm 30 Tue Dec 2025

Lot size of AUROPHARMA is: 550

Time	Option Price	Open Interest	Open	High	Low
3:29pm	0.05	57750	0.80	7.10	0.05
3:28pm	0.05	57750	0.80	7.10	0.05
3:27pm	0.05	57750	0.80	7.10	0.05
3:24pm	0.05	57750	0.80	7.10	0.05
3:23pm	0.05	57750	0.80	7.10	0.05
3:21pm	0.05	57750	0.80	7.10	0.05
3:20pm	0.05	57750	0.80	7.10	0.05
3:18pm	0.05	57750	0.80	7.10	0.05
3:16pm	0.05	57750	0.80	7.10	0.05
3:15pm	0.05	57750	0.80	7.10	0.05

option chart AUROPHARMA PE 1180.00 2025-12-30

White line on the chart is the option premium, and gray line just under it is the open interest. Candle stick charts use day open, day high, day low, and current LTP of the premium. Please note that high low shadows are only plotted when a new high or low is made, otherwise, only candle body is plotted.

What is premium price of AUROPHARMA 1180.00 PE PUT today?: Premium of AUROPHARMA 1180.00 PE is 0.25 on 30 Dec 2025 PUT opened at 0.80 and traded inside a Low-High range of 0.05-7.10 today. Please click here table for more current prices.
What is open interest of AUROPHARMA 1180.00 PUT PE today?: Open Interest of AUROPHARMA 1180.00 PE is 57200 today. This has changed -59950.00 from previous day.
What is underlying price of AUROPHARMA 1180.00 PE PUT today?: Underlying price of AUROPHARMA 1180.00 PE PUT is 1186.30 today.
What is lot size of AUROPHARMA 1180.00 PUT PE today?: Lot size of AUROPHARMA 1180.00 PUT PE is 550.00
Is AUROPHARMA 1180.00 PE PUT ITM or OTM or ATM?: AUROPHARMA 1180.00 PUT PE is OTM PUT option (out of the money). Only ITM options have intrinsic value in them, while OTM options have only time value in them.

Underlying equity prev closing: 1186.30

AUROPHARMA PUT PE available options strikes

PE 1140, PE 1160, PE 1180, PE 1200, PE 1220, PE 1240, All CE , All PE

AUROPHARMA 1180.00 PUT PE available expiry dates

27 Jan 2026 24 Feb 2026

Premium of AUROPHARMA 1180.00 PUT PE December 30 2025

AUROPHARMA 1180.00 PE Live prices

Premium of PUT (PE) of strike 1180.00 is at: 0.25 on 30 Dec 2025
PUT opened at 0.80 and traded inside a Low-High range of 0.05-7.10 as on 30 Tue Dec 2025

The underlying equity is trading at 1186.30 which means that PUT of strike 1180.00 is OTM PUT option (out of the money)

Lot size of AUROPHARMA Aurobindo Pharma Limited is 550

Total Open Interest for PUT (PE) of strike 1180.00 is 57,200

Price action analysis of 1180.00 PUT based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.

Click here to view most profitable CE and PE for Aurobindo Pharma Limited, both for buyers and sellers | AUROPHARMA Most Active Call Put Options

Date	Underlying price	PE price	PE open	PE high	PE low	PE volume	PE OI	OI Change
30 Tue Dec	1186.30	0.25	0.80	7.10	0.05	-89	31,460,000	-51.2%
29 Mon Dec	1200.10	2.45	1.45	3.50	0.45	58	64,432,500	-58.3%
26 Fri Dec	1206.20	1.55	1.30	1.75	0.80	-27	154,577,500	-0.2%
24 Wed Dec	1211.40	2.15	3.15	3.15	1.90	-28	154,880,000	-13.5%
23 Tue Dec	1218.00	3.00	3.00	5.30	2.00	-15	179,080,000	2.4%
22 Mon Dec	1224.50	3.55	3.60	3.75	2.45	-17	174,845,000	-20.4%

Charts for AUROPHARMA 1180.00 PUT PE options for Aurobindo Pharma Limited

Select an expiry and a strike price below to view charts for those options. AUROPHARMA All in One charts

Charts for:

Dark shadowed line on the chart below is the current SPOT price line of underlying equity. White line on the chart is the option closing price line. Candle sticks on the chart are the OHLC for the option.

AUROPHARMA further analysis